研究成果 (66)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/7

A B C D E F G H I L M N O P R S T U V Z 全部

A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma
Shi L, Zhang SJ, Chen J, Lu SX, Fan XJ, Tong JH, Chow C, Tin EK, Chan SL, Chong CC, Lai PB, To KF, Wong N, Chan AW ( 2019 )
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41379-019-0307-8
Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis
Ming-Yue Li, Li-Zhong Liu, Wende Li, Calvin S. H. Ng, Yi Liu, Angel W. Y. Kong, Zhili Zhao, Shanshan Wang, Haolong Qi, Hao Jia, Shucai Yang, Jing Du, Xiang Long, Rocky L. K. Ho, Ernest C. W. Chak, Innes Y. P. Wan, Tony S. K. Mok, Malcolm J. Underwood, Nirmal Kumar Gali, Zhi Ning, George G. Chen ( 2019 )
Journal of experimental & clinical cancer research : CR
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1186/s13046-019-1380-z
Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment response
Qamar S, King AD, Ai QY, Law BKH, Chan JSM, Poon DMC, Tong M, Mo FKF, Chen W, Bhatia KS, Ahuja AT, Ma BBY, Yeung DK, Wang YX, Yuan J ( 2019 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00405-018-5231-x
A multicenter phase II study of neoadjuvant FOLFOXIRI followed by concurrent capecitabine and radiotherapy for high risk rectal cancer: a final report
G Lam, M Tong, J Lee, S Chu, DC Ng, DCM Lam, C Cho, EH Hung, L Li, WM Ho, EP Hui, AW Chan, S Hon, T Mak, S Ng, J Suen, F Mo, BBY Ma ( 2019 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdz421.001
A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O‑6‑methylguanine‑DNA methyltransferase
Woo Peter YM, Li Yi, Chan Anna HY, Ng Stephanie CP, Loong Herbert HF, Chan Danny TM, Wong George KC, Poon Wai‑San ( 2019 )
Glioma
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.4103/glioma.glioma_3_19
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Qin SK, Chan SL, Sukeepaisarnjaroen W, Han GH, Choo SP, Sriuranpong V, Pan HM, Yau T, Guo YB, Chen MS, Ren ZG, Xu JM, Yen CJ, Lin ZZ, Manenti L, Gu Y, Sun YJ, Tiedt R, Hao L, Song WJ, Tanwandee T ( 2019 )
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
Publication in refereed journal
典藏於此文庫的全文:
144260096.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1177/1758835919889001
A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy
Molassiotis A, Suen LKP, Cheng HL, Mok TSK, Lee SCY, Wang CH, Lee P, Leung H, Chan V, Lau TKH, Yeo W ( 2019 )
INTEGRATIVE CANCER THERAPIES
Publication in refereed journal
典藏於此文庫的全文:
1534735419836501.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1177/1534735419836501
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA, IMpower150 Study Group ( 2019 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S2213-2600(19)30084-0
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
Eng C, Kim TW, Bendell J, Argilés G, Tebbutt NC, Di Bartolomeo M, Falcone A, Fakih M, Kozloff M, Segal NH, Sobrero A, Yan Y, Chang I, Uyei A, Roberts L, Ciardiello F, IMblaze370 Investigators: Ma B ( 2019 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S1470-2045(19)30027-0
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Galle PR, Foerster F, Kudo M, Chan SL, Llovet JM, Qin SK, Schelman WR, Chintharlapalli S, Abada PB, Sherman M, Zhu AX ( 2019 )
LIVER INTERNATIONAL
Publication in refereed journal
典藏於此文庫的全文:
144261180.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1111/liv.14223

10 | 25 | 50 | 100

1/7

研究成果 (66)

分享連結

Our policy towards the use of cookies